These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 12491405)

  • 1. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.
    Bom A; Bradley M; Cameron K; Clark JK; Van Egmond J; Feilden H; MacLean EJ; Muir AW; Palin R; Rees DC; Zhang MQ
    Angew Chem Int Ed Engl; 2002 Jan; 41(2):266-70. PubMed ID: 12491405
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships.
    Adam JM; Bennett DJ; Bom A; Clark JK; Feilden H; Hutchinson EJ; Palin R; Prosser A; Rees DC; Rosair GM; Stevenson D; Tarver GJ; Zhang MQ
    J Med Chem; 2002 Apr; 45(9):1806-16. PubMed ID: 11960492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-O-substituted cyclodextrins as reversal agents for the neuromuscular blocker rocuronium bromide.
    Tarver GJ; Grove SJ; Buchanan K; Bom A; Cooke A; Rutherford SJ; Zhang MQ
    Bioorg Med Chem; 2002 Jun; 10(6):1819-27. PubMed ID: 11937340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery].
    Øberg E; Claudius C
    Ugeskr Laeger; 2013 Feb; 175(7):428-32. PubMed ID: 23402253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Feb; 96(2):201-6. PubMed ID: 16377646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex-rocuronium dosing.
    Kopman AF
    Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
    [No Abstract]   [Full Text] [Related]  

  • 10. Modified gamma-cyclodextrins and their rocuronium complexes.
    Cameron KS; Clark JK; Cooper A; Fielding L; Palin R; Rutherford SJ; Zhang MQ
    Org Lett; 2002 Oct; 4(20):3403-6. PubMed ID: 12323029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy.
    Baldo BA; McDonnell NJ; Pham NH
    Clin Exp Allergy; 2011 Dec; 41(12):1663-78. PubMed ID: 21732999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.
    de Boer HD; Driessen JJ; van Egmond J; Booij LH
    Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969.
    Epemolu O; Bom A; Hope F; Mason R
    Anesthesiology; 2003 Sep; 99(3):632-7; discussion 6A. PubMed ID: 12960547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats.
    Staals LM; de Boer HD; van Egmond J; Hope F; van de Pol F; Bom AH; Driessen JJ; Booij LH
    J Anesth; 2011 Apr; 25(2):241-6. PubMed ID: 21225291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-establishment of neuromuscular block by rocuronium after sugammadex administration.
    Fabregat-López J; Veiga-Ruiz G; Dominguez-Serrano N; García-Martinez MR
    Can J Anaesth; 2011 Jul; 58(7):658. PubMed ID: 21468657
    [No Abstract]   [Full Text] [Related]  

  • 18. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex.
    Langley RJ; McFadzean J; McCormack J
    Paediatr Anaesth; 2016 Jan; 26(1):109-11. PubMed ID: 26456087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.